Global Rapid Diagnostic Testing for Influenza Market Research Report 2023

Rapid Diagnostic Testing for Influenza Market

Rapid influenza diagnostic tests (RIDTs) are immunoassays that can identify the presence of influenza A and B viral nucleoprotein antigens in respiratory specimens, and display the result in a qualitative way (positive vs. negative). In the United States, a number of RIDTs are commercially available. The reference standards for laboratory confirmation of influenza virus infection in respiratory specimens are reverse transcription-polymerase chain reaction (RT-PCR) or viral culture. RIDTs can yield results in a clinically relevant time frame, i.e., less than approximately 15 minutes. However, RIDTs have limited sensitivity to detect influenza viruses in respiratory specimens compared to RT-PCR or viral culture and negative RIDT test results should be interpreted with caution given the potential for false negative results, especially during peak influenza activity in a community. Some RIDTs use analyzer reader devices to standardize result interpretation.

Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Rapid Diagnostic Testing for Influenza market research.

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Scope

This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Rapid Diagnostic Testing for Influenza market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.

Scope of Rapid Diagnostic Testing for Influenza Market Report

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Rapid Diagnostic Testing for Influenza Market Size Growth Rate by Type: 2018 VS 2022 VS 2029

1.2.2 Digital RIDTs

1.2.3 Conventional RIDT

1.3 Market by Application

1.3.1 Global Rapid Diagnostic Testing for Influenza Market Growth by Application: 2018 VS 2022 VS 2029

1.3.2 Hospitals

1.3.3 POCT

1.3.4 Others

1.4 Study Objectives

1.5 Years Considered

1.6 Years Considered

2.1 Global Rapid Diagnostic Testing for Influenza Market Perspective (2018-2029)

2.2 Rapid Diagnostic Testing for Influenza Growth Trends by Region

2.2.1 Global Rapid Diagnostic Testing for Influenza Market Size by Region: 2018 VS 2022 VS 2029

2.2.2 Rapid Diagnostic Testing for Influenza Historic Market Size by Region (2018-2023)

2.2.3 Rapid Diagnostic Testing for Influenza Forecasted Market Size by Region (2024-2029)

2.3 Rapid Diagnostic Testing for Influenza Market Dynamics

2.3.1 Rapid Diagnostic Testing for Influenza Industry Trends

2.3.2 Rapid Diagnostic Testing for Influenza Market Drivers

2.3.3 Rapid Diagnostic Testing for Influenza Market Challenges

2.3.4 Rapid Diagnostic Testing for Influenza Market Restraints

3.1 Global Top Rapid Diagnostic Testing for Influenza Players by Revenue

3.1.1 Global Top Rapid Diagnostic Testing for Influenza Players by Revenue (2018-2023)

3.1.2 Global Rapid Diagnostic Testing for Influenza Revenue Market Share by Players (2018-2023)

3.2 Global Rapid Diagnostic Testing for Influenza Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Players Covered: Ranking by Rapid Diagnostic Testing for Influenza Revenue

3.4 Global Rapid Diagnostic Testing for Influenza Market Concentration Ratio

3.4.1 Global Rapid Diagnostic Testing for Influenza Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Rapid Diagnostic Testing for Influenza Revenue in 2022

3.5 Rapid Diagnostic Testing for Influenza Key Players Head office and Area Served

3.6 Key Players Rapid Diagnostic Testing for Influenza Product Solution and Service

3.7 Date of Enter into Rapid Diagnostic Testing for Influenza Market

3.8 Mergers & Acquisitions, Expansion Plans

4.1 Global Rapid Diagnostic Testing for Influenza Historic Market Size by Type (2018-2023)

4.2 Global Rapid Diagnostic Testing for Influenza Forecasted Market Size by Type (2024-2029)

5.1 Global Rapid Diagnostic Testing for Influenza Historic Market Size by Application (2018-2023)

5.2 Global Rapid Diagnostic Testing for Influenza Forecasted Market Size by Application (2024-2029)

6.1 North America Rapid Diagnostic Testing for Influenza Market Size (2018-2029)

6.2 North America Rapid Diagnostic Testing for Influenza Market Growth Rate by Country: 2018 VS 2022 VS 2029

6.3 North America Rapid Diagnostic Testing for Influenza Market Size by Country (2018-2023)

6.4 North America Rapid Diagnostic Testing for Influenza Market Size by Country (2024-2029)

6.5 United States

6.6 Canada

7.1 Europe Rapid Diagnostic Testing for Influenza Market Size (2018-2029)

7.2 Europe Rapid Diagnostic Testing for Influenza Market Growth Rate by Country: 2018 VS 2022 VS 2029

7.3 Europe Rapid Diagnostic Testing for Influenza Market Size by Country (2018-2023)

7.4 Europe Rapid Diagnostic Testing for Influenza Market Size by Country (2024-2029)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8.1 Asia-Pacific Rapid Diagnostic Testing for Influenza Market Size (2018-2029)

8.2 Asia-Pacific Rapid Diagnostic Testing for Influenza Market Growth Rate by Region: 2018 VS 2022 VS 2029

8.3 Asia-Pacific Rapid Diagnostic Testing for Influenza Market Size by Region (2018-2023)

8.4 Asia-Pacific Rapid Diagnostic Testing for Influenza Market Size by Region (2024-2029)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9.1 Latin America Rapid Diagnostic Testing for Influenza Market Size (2018-2029)

9.2 Latin America Rapid Diagnostic Testing for Influenza Market Growth Rate by Country: 2018 VS 2022 VS 2029

9.3 Latin America Rapid Diagnostic Testing for Influenza Market Size by Country (2018-2023)

9.4 Latin America Rapid Diagnostic Testing for Influenza Market Size by Country (2024-2029)

9.5 Mexico

9.6 Brazil

10.1 Middle East & Africa Rapid Diagnostic Testing for Influenza Market Size (2018-2029)

10.2 Middle East & Africa Rapid Diagnostic Testing for Influenza Market Growth Rate by Country: 2018 VS 2022 VS 2029

10.3 Middle East & Africa Rapid Diagnostic Testing for Influenza Market Size by Country (2018-2023)

10.4 Middle East & Africa Rapid Diagnostic Testing for Influenza Market Size by Country (2024-2029)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11.1 BD

11.1.1 BD Company Detail

11.1.2 BD Business Overview

11.1.3 BD Rapid Diagnostic Testing for Influenza Introduction

11.1.4 BD Revenue in Rapid Diagnostic Testing for Influenza Business (2018-2023)

11.1.5 BD Recent Development

11.2 Abbot (Alere)

11.2.1 Abbot (Alere) Company Detail

11.2.2 Abbot (Alere) Business Overview

11.2.3 Abbot (Alere) Rapid Diagnostic Testing for Influenza Introduction

11.2.4 Abbot (Alere) Revenue in Rapid Diagnostic Testing for Influenza Business (2018-2023)

11.2.5 Abbot (Alere) Recent Development

11.3 Quidel

11.3.1 Quidel Company Detail

11.3.2 Quidel Business Overview

11.3.3 Quidel Rapid Diagnostic Testing for Influenza Introduction

11.3.4 Quidel Revenue in Rapid Diagnostic Testing for Influenza Business (2018-2023)

11.3.5 Quidel Recent Development

11.4 Roche

11.4.1 Roche Company Detail

11.4.2 Roche Business Overview

11.4.3 Roche Rapid Diagnostic Testing for Influenza Introduction

11.4.4 Roche Revenue in Rapid Diagnostic Testing for Influenza Business (2018-2023)

11.4.5 Roche Recent Development

11.5 Thermo Fisher Scientific

11.5.1 Thermo Fisher Scientific Company Detail

11.5.2 Thermo Fisher Scientific Business Overview

11.5.3 Thermo Fisher Scientific Rapid Diagnostic Testing for Influenza Introduction

11.5.4 Thermo Fisher Scientific Revenue in Rapid Diagnostic Testing for Influenza Business (2018-2023)

11.5.5 Thermo Fisher Scientific Recent Development

11.6 Meridian Bioscience

11.6.1 Meridian Bioscience Company Detail

11.6.2 Meridian Bioscience Business Overview

11.6.3 Meridian Bioscience Rapid Diagnostic Testing for Influenza Introduction

11.6.4 Meridian Bioscience Revenue in Rapid Diagnostic Testing for Influenza Business (2018-2023)

11.6.5 Meridian Bioscience Recent Development

11.7 Analytik Jena

11.7.1 Analytik Jena Company Detail

11.7.2 Analytik Jena Business Overview

11.7.3 Analytik Jena Rapid Diagnostic Testing for Influenza Introduction

11.7.4 Analytik Jena Revenue in Rapid Diagnostic Testing for Influenza Business (2018-2023)

11.7.5 Analytik Jena Recent Development

11.8 Princeton BioMeditech Corporation

11.8.1 Princeton BioMeditech Corporation Company Detail

11.8.2 Princeton BioMeditech Corporation Business Overview

11.8.3 Princeton BioMeditech Corporation Rapid Diagnostic Testing for Influenza Introduction

11.8.4 Princeton BioMeditech Corporation Revenue in Rapid Diagnostic Testing for Influenza Business (2018-2023)

11.8.5 Princeton BioMeditech Corporation Recent Development

11.9 BioMerieux

11.9.1 BioMerieux Company Detail

11.9.2 BioMerieux Business Overview

11.9.3 BioMerieux Rapid Diagnostic Testing for Influenza Introduction

11.9.4 BioMerieux Revenue in Rapid Diagnostic Testing for Influenza Business (2018-2023)

11.9.5 BioMerieux Recent Development

11.10 Sekisui Diagnostics

11.10.1 Sekisui Diagnostics Company Detail

11.10.2 Sekisui Diagnostics Business Overview

11.10.3 Sekisui Diagnostics Rapid Diagnostic Testing for Influenza Introduction

11.10.4 Sekisui Diagnostics Revenue in Rapid Diagnostic Testing for Influenza Business (2018-2023)

11.10.5 Sekisui Diagnostics Recent Development

11.11 Response Biomedical

11.11.1 Response Biomedical Company Detail

11.11.2 Response Biomedical Business Overview

11.11.3 Response Biomedical Rapid Diagnostic Testing for Influenza Introduction

11.11.4 Response Biomedical Revenue in Rapid Diagnostic Testing for Influenza Business (2018-2023)

11.11.5 Response Biomedical Recent Development

11.12 SA Scientific

11.12.1 SA Scientific Company Detail

11.12.2 SA Scientific Business Overview

11.12.3 SA Scientific Rapid Diagnostic Testing for Influenza Introduction

11.12.4 SA Scientific Revenue in Rapid Diagnostic Testing for Influenza Business (2018-2023)

11.12.5 SA Scientific Recent Development

11.13 DiaSorin (Focus Diagnostics)

11.13.1 DiaSorin (Focus Diagnostics) Company Detail

11.13.2 DiaSorin (Focus Diagnostics) Business Overview

11.13.3 DiaSorin (Focus Diagnostics) Rapid Diagnostic Testing for Influenza Introduction

11.13.4 DiaSorin (Focus Diagnostics) Revenue in Rapid Diagnostic Testing for Influenza Business (2018-2023)

11.13.5 DiaSorin (Focus Diagnostics) Recent Development

11.14 Wondfo

11.14.1 Wondfo Company Detail

11.14.2 Wondfo Business Overview

11.14.3 Wondfo Rapid Diagnostic Testing for Influenza Introduction

11.14.4 Wondfo Revenue in Rapid Diagnostic Testing for Influenza Business (2018-2023)

11.14.5 Wondfo Recent Development

11.15 Beijing Wantai Biological Pharmacy

11.15.1 Beijing Wantai Biological Pharmacy Company Detail

11.15.2 Beijing Wantai Biological Pharmacy Business Overview

11.15.3 Beijing Wantai Biological Pharmacy Rapid Diagnostic Testing for Influenza Introduction

11.15.4 Beijing Wantai Biological Pharmacy Revenue in Rapid Diagnostic Testing for Influenza Business (2018-2023)

11.15.5 Beijing Wantai Biological Pharmacy Recent Development

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.2 Data Source

13.2 Disclaimer

13.3 Author Details

List of Tables

    Table 1. Global Rapid Diagnostic Testing for Influenza Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2029

    Table 2. Key Players of Digital RIDTs

    Table 3. Key Players of Conventional RIDT

    Table 4. Global Rapid Diagnostic Testing for Influenza Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2029

    Table 5. Global Rapid Diagnostic Testing for Influenza Market Size by Region (US$ Million): 2018 VS 2022 VS 2029

    Table 6. Global Rapid Diagnostic Testing for Influenza Market Size by Region (2018-2023) & (US$ Million)

    Table 7. Global Rapid Diagnostic Testing for Influenza Market Share by Region (2018-2023)

    Table 8. Global Rapid Diagnostic Testing for Influenza Forecasted Market Size by Region (2024-2029) & (US$ Million)

    Table 9. Global Rapid Diagnostic Testing for Influenza Market Share by Region (2024-2029)

    Table 10. Rapid Diagnostic Testing for Influenza Market Trends

    Table 11. Rapid Diagnostic Testing for Influenza Market Drivers

    Table 12. Rapid Diagnostic Testing for Influenza Market Challenges

    Table 13. Rapid Diagnostic Testing for Influenza Market Restraints

    Table 14. Global Rapid Diagnostic Testing for Influenza Revenue by Players (2018-2023) & (US$ Million)

    Table 15. Global Rapid Diagnostic Testing for Influenza Market Share by Players (2018-2023)

    Table 16. Global Top Rapid Diagnostic Testing for Influenza Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Rapid Diagnostic Testing for Influenza as of 2022)

    Table 17. Ranking of Global Top Rapid Diagnostic Testing for Influenza Companies by Revenue (US$ Million) in 2022

    Table 18. Global 5 Largest Players Market Share by Rapid Diagnostic Testing for Influenza Revenue (CR5 and HHI) & (2018-2023)

    Table 19. Key Players Headquarters and Area Served

    Table 20. Key Players Rapid Diagnostic Testing for Influenza Product Solution and Service

    Table 21. Date of Enter into Rapid Diagnostic Testing for Influenza Market

    Table 22. Mergers & Acquisitions, Expansion Plans

    Table 23. Global Rapid Diagnostic Testing for Influenza Market Size by Type (2018-2023) & (US$ Million)

    Table 24. Global Rapid Diagnostic Testing for Influenza Revenue Market Share by Type (2018-2023)

    Table 25. Global Rapid Diagnostic Testing for Influenza Forecasted Market Size by Type (2024-2029) & (US$ Million)

    Table 26. Global Rapid Diagnostic Testing for Influenza Revenue Market Share by Type (2024-2029)

    Table 27. Global Rapid Diagnostic Testing for Influenza Market Size by Application (2018-2023) & (US$ Million)

    Table 28. Global Rapid Diagnostic Testing for Influenza Revenue Market Share by Application (2018-2023)

    Table 29. Global Rapid Diagnostic Testing for Influenza Forecasted Market Size by Application (2024-2029) & (US$ Million)

    Table 30. Global Rapid Diagnostic Testing for Influenza Revenue Market Share by Application (2024-2029)

    Table 31. North America Rapid Diagnostic Testing for Influenza Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029

    Table 32. North America Rapid Diagnostic Testing for Influenza Market Size by Country (2018-2023) & (US$ Million)

    Table 33. North America Rapid Diagnostic Testing for Influenza Market Size by Country (2024-2029) & (US$ Million)

    Table 34. Europe Rapid Diagnostic Testing for Influenza Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029

    Table 35. Europe Rapid Diagnostic Testing for Influenza Market Size by Country (2018-2023) & (US$ Million)

    Table 36. Europe Rapid Diagnostic Testing for Influenza Market Size by Country (2024-2029) & (US$ Million)

    Table 37. Asia-Pacific Rapid Diagnostic Testing for Influenza Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2029

    Table 38. Asia-Pacific Rapid Diagnostic Testing for Influenza Market Size by Region (2018-2023) & (US$ Million)

    Table 39. Asia-Pacific Rapid Diagnostic Testing for Influenza Market Size by Region (2024-2029) & (US$ Million)

    Table 40. Latin America Rapid Diagnostic Testing for Influenza Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029

    Table 41. Latin America Rapid Diagnostic Testing for Influenza Market Size by Country (2018-2023) & (US$ Million)

    Table 42. Latin America Rapid Diagnostic Testing for Influenza Market Size by Country (2024-2029) & (US$ Million)

    Table 43. Middle East & Africa Rapid Diagnostic Testing for Influenza Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029

    Table 44. Middle East & Africa Rapid Diagnostic Testing for Influenza Market Size by Country (2018-2023) & (US$ Million)

    Table 45. Middle East & Africa Rapid Diagnostic Testing for Influenza Market Size by Country (2024-2029) & (US$ Million)

    Table 46. BD Company Detail

    Table 47. BD Business Overview

    Table 48. BD Rapid Diagnostic Testing for Influenza Product

    Table 49. BD Revenue in Rapid Diagnostic Testing for Influenza Business (2018-2023) & (US$ Million)

    Table 50. BD Recent Development

    Table 51. Abbot (Alere) Company Detail

    Table 52. Abbot (Alere) Business Overview

    Table 53. Abbot (Alere) Rapid Diagnostic Testing for Influenza Product

    Table 54. Abbot (Alere) Revenue in Rapid Diagnostic Testing for Influenza Business (2018-2023) & (US$ Million)

    Table 55. Abbot (Alere) Recent Development

    Table 56. Quidel Company Detail

    Table 57. Quidel Business Overview

    Table 58. Quidel Rapid Diagnostic Testing for Influenza Product

    Table 59. Quidel Revenue in Rapid Diagnostic Testing for Influenza Business (2018-2023) & (US$ Million)

    Table 60. Quidel Recent Development

    Table 61. Roche Company Detail

    Table 62. Roche Business Overview

    Table 63. Roche Rapid Diagnostic Testing for Influenza Product

    Table 64. Roche Revenue in Rapid Diagnostic Testing for Influenza Business (2018-2023) & (US$ Million)

    Table 65. Roche Recent Development

    Table 66. Thermo Fisher Scientific Company Detail

    Table 67. Thermo Fisher Scientific Business Overview

    Table 68. Thermo Fisher Scientific Rapid Diagnostic Testing for Influenza Product

    Table 69. Thermo Fisher Scientific Revenue in Rapid Diagnostic Testing for Influenza Business (2018-2023) & (US$ Million)

    Table 70. Thermo Fisher Scientific Recent Development

    Table 71. Meridian Bioscience Company Detail

    Table 72. Meridian Bioscience Business Overview

    Table 73. Meridian Bioscience Rapid Diagnostic Testing for Influenza Product

    Table 74. Meridian Bioscience Revenue in Rapid Diagnostic Testing for Influenza Business (2018-2023) & (US$ Million)

    Table 75. Meridian Bioscience Recent Development

    Table 76. Analytik Jena Company Detail

    Table 77. Analytik Jena Business Overview

    Table 78. Analytik Jena Rapid Diagnostic Testing for Influenza Product

    Table 79. Analytik Jena Revenue in Rapid Diagnostic Testing for Influenza Business (2018-2023) & (US$ Million)

    Table 80. Analytik Jena Recent Development

    Table 81. Princeton BioMeditech Corporation Company Detail

    Table 82. Princeton BioMeditech Corporation Business Overview

    Table 83. Princeton BioMeditech Corporation Rapid Diagnostic Testing for Influenza Product

    Table 84. Princeton BioMeditech Corporation Revenue in Rapid Diagnostic Testing for Influenza Business (2018-2023) & (US$ Million)

    Table 85. Princeton BioMeditech Corporation Recent Development

    Table 86. BioMerieux Company Detail

    Table 87. BioMerieux Business Overview

    Table 88. BioMerieux Rapid Diagnostic Testing for Influenza Product

    Table 89. BioMerieux Revenue in Rapid Diagnostic Testing for Influenza Business (2018-2023) & (US$ Million)

    Table 90. BioMerieux Recent Development

    Table 91. Sekisui Diagnostics Company Detail

    Table 92. Sekisui Diagnostics Business Overview

    Table 93. Sekisui Diagnostics Rapid Diagnostic Testing for Influenza Product

    Table 94. Sekisui Diagnostics Revenue in Rapid Diagnostic Testing for Influenza Business (2018-2023) & (US$ Million)

    Table 95. Sekisui Diagnostics Recent Development

    Table 96. Response Biomedical Company Detail

    Table 97. Response Biomedical Business Overview

    Table 98. Response Biomedical Rapid Diagnostic Testing for Influenza Product

    Table 99. Response Biomedical Revenue in Rapid Diagnostic Testing for Influenza Business (2018-2023) & (US$ Million)

    Table 100. Response Biomedical Recent Development

    Table 101. SA Scientific Company Detail

    Table 102. SA Scientific Business Overview

    Table 103. SA Scientific Rapid Diagnostic Testing for Influenza Product

    Table 104. SA Scientific Revenue in Rapid Diagnostic Testing for Influenza Business (2018-2023) & (US$ Million)

    Table 105. SA Scientific Recent Development

    Table 106. DiaSorin (Focus Diagnostics) Company Detail

    Table 107. DiaSorin (Focus Diagnostics) Business Overview

    Table 108. DiaSorin (Focus Diagnostics) Rapid Diagnostic Testing for Influenza Product

    Table 109. DiaSorin (Focus Diagnostics) Revenue in Rapid Diagnostic Testing for Influenza Business (2018-2023) & (US$ Million)

    Table 110. DiaSorin (Focus Diagnostics) Recent Development

    Table 111. Wondfo Company Detail

    Table 112. Wondfo Business Overview

    Table 113. Wondfo Rapid Diagnostic Testing for Influenza Product

    Table 114. Wondfo Revenue in Rapid Diagnostic Testing for Influenza Business (2018-2023) & (US$ Million)

    Table 115. Wondfo Recent Development

    Table 116. Beijing Wantai Biological Pharmacy Company Detail

    Table 117. Beijing Wantai Biological Pharmacy Business Overview

    Table 118. Beijing Wantai Biological Pharmacy Rapid Diagnostic Testing for Influenza Product

    Table 119. Beijing Wantai Biological Pharmacy Revenue in Rapid Diagnostic Testing for Influenza Business (2018-2023) & (US$ Million)

    Table 120. Beijing Wantai Biological Pharmacy Recent Development

    Table 121. Research Programs/Design for This Report

    Table 122. Key Data Information from Secondary Sources

    Table 123. Key Data Information from Primary Sources

List of Figures

    Figure 1. Global Rapid Diagnostic Testing for Influenza Market Size Comparison by Type (2023-2029) & (US$ Million)

    Figure 2. Global Rapid Diagnostic Testing for Influenza Market Share by Type: 2022 VS 2029

    Figure 3. Digital RIDTs Features

    Figure 4. Conventional RIDT Features

    Figure 5. Global Rapid Diagnostic Testing for Influenza Market Size Comparison by Application (2023-2029) & (US$ Million)

    Figure 6. Global Rapid Diagnostic Testing for Influenza Market Share by Application: 2022 VS 2029

    Figure 7. Hospitals Case Studies

    Figure 8. POCT Case Studies

    Figure 9. Others Case Studies

    Figure 10. Rapid Diagnostic Testing for Influenza Report Years Considered

    Figure 11. Global Rapid Diagnostic Testing for Influenza Market Size (US$ Million), Year-over-Year: 2018-2029

    Figure 12. Global Rapid Diagnostic Testing for Influenza Market Size, (US$ Million), 2018 VS 2022 VS 2029

    Figure 13. Global Rapid Diagnostic Testing for Influenza Market Share by Region: 2022 VS 2029

    Figure 14. Global Rapid Diagnostic Testing for Influenza Market Share by Players in 2022

    Figure 15. Global Top Rapid Diagnostic Testing for Influenza Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Rapid Diagnostic Testing for Influenza as of 2022)

    Figure 16. The Top 10 and 5 Players Market Share by Rapid Diagnostic Testing for Influenza Revenue in 2022

    Figure 17. North America Rapid Diagnostic Testing for Influenza Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 18. North America Rapid Diagnostic Testing for Influenza Market Share by Country (2018-2029)

    Figure 19. United States Rapid Diagnostic Testing for Influenza Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 20. Canada Rapid Diagnostic Testing for Influenza Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 21. Europe Rapid Diagnostic Testing for Influenza Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 22. Europe Rapid Diagnostic Testing for Influenza Market Share by Country (2018-2029)

    Figure 23. Germany Rapid Diagnostic Testing for Influenza Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 24. France Rapid Diagnostic Testing for Influenza Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 25. U.K. Rapid Diagnostic Testing for Influenza Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 26. Italy Rapid Diagnostic Testing for Influenza Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 27. Russia Rapid Diagnostic Testing for Influenza Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 28. Nordic Countries Rapid Diagnostic Testing for Influenza Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 29. Asia-Pacific Rapid Diagnostic Testing for Influenza Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 30. Asia-Pacific Rapid Diagnostic Testing for Influenza Market Share by Region (2018-2029)

    Figure 31. China Rapid Diagnostic Testing for Influenza Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 32. Japan Rapid Diagnostic Testing for Influenza Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 33. South Korea Rapid Diagnostic Testing for Influenza Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 34. Southeast Asia Rapid Diagnostic Testing for Influenza Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 35. India Rapid Diagnostic Testing for Influenza Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 36. Australia Rapid Diagnostic Testing for Influenza Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 37. Latin America Rapid Diagnostic Testing for Influenza Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 38. Latin America Rapid Diagnostic Testing for Influenza Market Share by Country (2018-2029)

    Figure 39. Mexico Rapid Diagnostic Testing for Influenza Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 40. Brazil Rapid Diagnostic Testing for Influenza Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 41. Middle East & Africa Rapid Diagnostic Testing for Influenza Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 42. Middle East & Africa Rapid Diagnostic Testing for Influenza Market Share by Country (2018-2029)

    Figure 43. Turkey Rapid Diagnostic Testing for Influenza Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 44. Saudi Arabia Rapid Diagnostic Testing for Influenza Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 45. BD Revenue Growth Rate in Rapid Diagnostic Testing for Influenza Business (2018-2023)

    Figure 46. Abbot (Alere) Revenue Growth Rate in Rapid Diagnostic Testing for Influenza Business (2018-2023)

    Figure 47. Quidel Revenue Growth Rate in Rapid Diagnostic Testing for Influenza Business (2018-2023)

    Figure 48. Roche Revenue Growth Rate in Rapid Diagnostic Testing for Influenza Business (2018-2023)

    Figure 49. Thermo Fisher Scientific Revenue Growth Rate in Rapid Diagnostic Testing for Influenza Business (2018-2023)

    Figure 50. Meridian Bioscience Revenue Growth Rate in Rapid Diagnostic Testing for Influenza Business (2018-2023)

    Figure 51. Analytik Jena Revenue Growth Rate in Rapid Diagnostic Testing for Influenza Business (2018-2023)

    Figure 52. Princeton BioMeditech Corporation Revenue Growth Rate in Rapid Diagnostic Testing for Influenza Business (2018-2023)

    Figure 53. BioMerieux Revenue Growth Rate in Rapid Diagnostic Testing for Influenza Business (2018-2023)

    Figure 54. Sekisui Diagnostics Revenue Growth Rate in Rapid Diagnostic Testing for Influenza Business (2018-2023)

    Figure 55. Response Biomedical Revenue Growth Rate in Rapid Diagnostic Testing for Influenza Business (2018-2023)

    Figure 56. SA Scientific Revenue Growth Rate in Rapid Diagnostic Testing for Influenza Business (2018-2023)

    Figure 57. DiaSorin (Focus Diagnostics) Revenue Growth Rate in Rapid Diagnostic Testing for Influenza Business (2018-2023)

    Figure 58. Wondfo Revenue Growth Rate in Rapid Diagnostic Testing for Influenza Business (2018-2023)

    Figure 59. Beijing Wantai Biological Pharmacy Revenue Growth Rate in Rapid Diagnostic Testing for Influenza Business (2018-2023)

    Figure 60. Bottom-up and Top-down Approaches for This Report

    Figure 61. Data Triangulation

    Figure 62. Key Executives Interviewed